Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Green Cross Health's Enterprise Value is NZ$393.0 Mil.
Green Cross Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$37.4 Mil. Therefore, Green Cross Health's EV-to-EBIT ratio for today is 10.50.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Green Cross Health's Enterprise Value is NZ$393.0 Mil.
Green Cross Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$58.0 Mil. Therefore, Green Cross Health's EV-to-EBITDA ratio for today is 6.78.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Green Cross Health's Enterprise Value is NZ$393.0 Mil.
Green Cross Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$544.5 Mil. Therefore, Green Cross Health's EV-to-Revenue ratio for today is 0.72.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Green Cross Health (NZSE:GXH) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Green Cross Health's current Enterprise Value is NZ$393.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Green Cross Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$37.4 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Green Cross Health's current Enterprise Value is NZ$393.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Green Cross Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$58.0 Mil.
Green Cross Health's current Enterprise Value is NZ$393.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Green Cross Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$544.5 Mil.
Green Cross Health's current Enterprise Value is NZ$393.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Green Cross Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$54.6 Mil.
Green Cross Health's current Enterprise Value is NZ$393.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Green Cross Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$45.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Cross Health Enterprise Value Related Terms
Green Cross Health Enterprise Value Historical Data
* Premium members only.
The historical data trend for Green Cross Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Cross Health Enterprise Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Green Cross Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Cross Health Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Green Cross Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Green Cross Health's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Green Cross Health's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of NZ$393.0 Mil mean?
Green Cross Health (NZSE:GXH) has a Enterprise Value of NZ$393.0 Mil as of Aug. 05, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Green Cross Health and its competitors.
Is Green Cross Health's Enterprise Value too high?
Green Cross Health's current Enterprise Value is NZ$393.0 Mil. Overall, Green Cross Health has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Cross Health's Enterprise Value compare to competitors?
Green Cross Health's Enterprise Value of NZ$393.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Green Cross Health and its competitors. Green Cross Health's current Enterprise Value is NZ$393.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Cross Health stock overvalued right now?
Based on GuruFocus' analysis, Green Cross Health (NZSE:GXH) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$1.08, compared to a current price of NZ$1.96 — trading 81.5% above its estimated fair value. The current Enterprise Value is NZ$393.0 Mil. Green Cross Health's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Green Cross Health (NZSE:GXH), the current Enterprise Value is NZ$393.0 Mil as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Cross Health (NZSE:GXH) Overvalued in 2026?
Based on GuruFocus' analysis, Green Cross Health stock appears to be overvalued.
The current stock price of NZ$1.96 is trading 81.5% above its estimated GF Value™ of NZ$1.08.
GuruFocus considers Green Cross Health to be Significantly Overvalued.
Key valuation signals for NZSE:GXH:
Enterprise Value: NZ$393.0 Mil
GF Value™: NZ$1.08 vs. price of NZ$1.96 (81.5% above fair value)
No single metric tells the full story. See the NZSE:GXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services and medical services. The majority of the revenue is generated from the Pharmacy services segment. The pharmacy services segment provides retail and dispensary services, and the medical services segment provides GP, nursing, and urgent care services. The majority of its revenue is generated from the pharmacy segment.
63GF Score
Get the complete analysis for NZSE:GXH
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:GXH has been successfully added to your 
